We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
In USA TODAY: When a 12-year-old experienced numbing inflammation, then paralysis, a plasma-based medicine was the answer.
Different than an IV, this method delivers medicine below the skin and can be self-administered by some patients.
Learn more about this commonly misdiagnosed disease associated with weakness, numbness and tingling in the arms and legs.
An expert nurse offers advice for patients who self-infuse medicines at home.
Learn more about this rare neurological disorder.
In nine years of managing her CIDP, Rosemarie acknowledges limits but also treasures her energy.
Caroline, a CIDP patient, created a canvas of light and hope to capture the treatment phase.
An end to confusion: CIDP patient Darryl paints the relief of diagnosis.
What was life like before diagnosis? CIDP patient Rohit picks up a brush to explain.
Tell your healthcare team about physical limitations, says CIDP patient Elizabeth Thirtyacre.
We asked patients for advice on managing their rare disease while traveling.
Patient advocates share stories to empower others living with similar conditions.
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
